Novonesis (Novozymes) B/ DK0060336014 /
| 2024-11-07 3:23:49 PM | Chg. -5.50 | Volume | Bid2024-09-25 | Ask2024-11-06 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 421.90DKK | -1.29% | 807 Turnover: 337,434.90 |
-Bid Size: - | -Ask Size: - | 116.33 bill.DKK | 1.00% | 38.42 |
Assets
|
2010 IFRS in mill. DKK |
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 5,866 | 6,557 | 7,084 | 7,135 | 7,498 | ||||||
| Intangible Assets | 1,070 | 2,221 | 2,672 | 2,864 | 2,954 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 14 | 29 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 1,640 | 1,741 | 1,808 | 1,902 | 2,184 | ||||||
| Accounts Receivable | 1,772 | 1,971 | 2,080 | 2,242 | 2,244 | ||||||
| Cash and Cash Equivalents | 1,465 | 667 | 535 | 1,003 | 2,535 | ||||||
| Current Assets | 5,536 | 4,789 | 4,890 | 5,686 | 7,311 | ||||||
| Total Assets | 12,593 | 13,842 | 15,113 | 16,506 | 18,426 | ||||||
Liabilities
|
2010 IFRS in mill. DKK |
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 764 | 745 | 1,044 | 976 | 1,122 | ||||||
| Long-term debt | - | 1,604 | 1,749 | 1,734 | 1,242 | ||||||
| Liabilities to Banks | 0.0000 | 1,862 | 2,035 | 1,839 | 1,972 | ||||||
| Provisions | 579 | 1,192 | 1,342 | 1,591 | 1,452 | ||||||
| Liabilities | 4,757 | 5,018 | 5,545 | 5,440 | 7,146 | ||||||
| Share Capital | 650 | 650 | 650 | 639 | 639 | ||||||
| Total Equity | 7,824 | 8,809 | 9,555 | 11,054 | 11,269 | ||||||
| Minority Interests | 12 | 15 | 13 | 12 | 11 | ||||||
| Total liabilities equity | 12,593 | 13,842 | 15,113 | 16,506 | 18,426 | ||||||
Income Statement
|
2010 IFRS in mill. DKK |
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 9,724 | 10,510 | 11,234 | 11,746 | 12,459 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 2,117 | 2,340 | 2,745 | 2,901 | 3,384 | ||||||
| Interest Income | 6 | 75 | -161 | -142 | -105 | ||||||
| Income Before Taxes | 2,123 | 2,415 | 2,584 | 2,759 | 3,279 | ||||||
| Income Taxes | 509 | 587 | 568 | 558 | 754 | ||||||
| Minority Interests Profit | -1 | -2 | -1 | -1 | 1 | ||||||
| Net Income | 1,613 | 1,826 | 2,015 | 2,200 | 2,526 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. DKK |
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,324 | 2,709 | 2,758 | 2,599 | 4,525 | ||||||
| Cash Flow from Investing Activities | -1,349 | -2,742 | -1,909 | -1,423 | -310 | ||||||
| Cash Flow from Financing | -737 | -656 | -1,165 | -532 | -2,703 | ||||||
| Decrease / Increase in Cash | 262 | -700 | -294 | 612 | 1,511 | ||||||
| Employees | 5,432 | 5,824 | 6,041 | 6,236 | 6,454 | ||||||
